Assessment of airspace levels of TGF-β or airway immune cell TGF-β expression during COVID-19 ARDS have been limited to a few reports based on understandable desire to limit aerosolization of sputum from COVID-19 patients to research or clinical personnel. The gene discussed is TGFB1; the disease is acute respiratory distress syndrome.